These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35814472)

  • 1. A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma.
    Hou J; Lu Z; Dong R; Wu G; Nie H; Yang G; Tang C; Qu G; Xu Y
    Front Oncol; 2022; 12():928204. PubMed ID: 35814472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma.
    Chen H; Xie Z; Li Q; Qu G; Tan N; Zhang Y
    Sci Rep; 2022 Jun; 12(1):11005. PubMed ID: 35768485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer.
    Hou J; Liang S; Xie Z; Qu G; Xu Y; Yang G; Tang C
    Sci Rep; 2022 Feb; 12(1):3225. PubMed ID: 35217715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer.
    Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L
    Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
    Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
    Lv J; Xu Q; Wu G; Hou J; Yang G; Tang C; Qu G; Xu Y
    Front Genet; 2022; 13():948254. PubMed ID: 36212132
    [No Abstract]   [Full Text] [Related]  

  • 7. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis.
    Cai D; Zhou Z; Wei G; Wu P; Kong G
    Front Genet; 2022; 13():952369. PubMed ID: 36118856
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma.
    Zhang T; Hei R; Huang Y; Shao J; Zhang M; Feng K; Qian W; Li S; Jin F; Chen Y
    Am J Cancer Res; 2023; 13(9):4418-4433. PubMed ID: 37818057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas.
    Liu B; Liu Z; Feng C; Tu C
    Front Genet; 2022; 13():899545. PubMed ID: 35795204
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer.
    Jiang K; Wu L; Yin X; Tang Q; Yin J; Zhou Z; Yu H; Yan S
    Front Genet; 2022; 13():1036098. PubMed ID: 36531246
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer.
    Ren W; Zuo S; Yang L; Tu R; Wang P; Zhang X
    Sci Rep; 2022 Mar; 12(1):3444. PubMed ID: 35236887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
    Xu M; Li Q; Zhang J; Xie H
    Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma.
    Tang C; Qu G; Xu Y; Yang G; Wang J; Xiang M
    Aging (Albany NY); 2021 Dec; 13(24):26046-26062. PubMed ID: 34954690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
    Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
    Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    Qian L; Ni T; Fei B; Sun H; Ni H
    BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma.
    Duan X; Du H; Yuan M; Liu L; Liu R; Shi J
    Exp Ther Med; 2023 Jul; 26(1):331. PubMed ID: 37346407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.